United States · FDA National Drug Code directory
BENZONATATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64380-713_53f9f0d6-4b7a-0e2e-e063-6394a90ab2c2
- Product NDC
- 64380-713
- Form
- CAPSULE
- Composition / generic term
- BENZONATATE
- Labeler
- Strides Pharma Science Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260529
- Source listing expiry
- 20271231
Source-listed ingredients
- BENZONATATE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 CONTAINER (64380-713-06) · 64380-713-06
- 500 CAPSULE in 1 BOTTLE (64380-713-07) · 64380-713-07
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →